PDZD4: A Potential Drug Target Or Biomarker (G57595)

Target Name: PDZD4

NCBI ID: G57595

PDZD4

PDZD4: A Potential Drug Target Or Biomarker

PDZD4 (PDZRN4L) is a protein that is expressed in various tissues of the body, including the brain, nervous system, and endocrine system. It is a member of the PDZ family, which is known for its role in development, maintenance, and plasticity. PDZD4 has been shown to play a role in a variety of physiological processes, including cell signaling, neurotransmission, and hormone regulation. As a result, PDZD4 has generated a lot of interest as a potential drug target or biomarker.

PDZD4 is a 21-kDa transmembrane protein that is expressed in the brain, spinal cord, and peripheral tissues. It is composed of a 126 amino acid protein that consists of a catalytic active site, a transmembrane region, and an intracellular tail. The catalytic active site is located at the center of the protein and is responsible for the catalytic activity of PDZD4. This active site is known to be involved in the regulation of a variety of cellular processes, including protein-protein interactions, tyrosination, and phosphorylation.

PDZD4 has been shown to play a role in a variety of physiological processes, including cell signaling, neurotransmission, and hormone regulation. For example, PDZD4 has been shown to be involved in the regulation of neurotransmitter release from neurons, which is important for the function of the nervous system. Additionally, PDZD4 has been shown to play a role in the regulation of hormone signaling, which is important for the regulation of various physiological processes in the endocrine system.

PDZD4 has also been shown to be involved in the regulation of cell proliferation and survival. For example, studies have shown that PDZD4 can inhibit the growth of cancer cells and promote the growth of healthy cells. This suggests that PDZD4 may be a useful target for cancer therapies.

PDZD4 has also been shown to be involved in the regulation of cellular signaling pathways that are important for the development and maintenance of tissues. For example, studies have shown that PDZD4 can be involved in the regulation of cell migration, which is important for the development and maintenance of tissues. Additionally, PDZD4 has been shown to be involved in the regulation of cell adhesion, which is important for the development and maintenance of tissues.

PDZD4 has also been shown to play a role in the regulation of neurotransmitter release from neurons, which is important for the function of the nervous system. For example, studies have shown that PDZD4 can inhibit the release of neurotransmitters from neurons and increase the release of other neurotransmitters. This suggests that PDZD4 may be a useful target for neurotransmitter therapies.

PDZD4 has also been shown to be involved in the regulation of the development and maintenance of the nervous system. For example, studies have shown that PDZD4 can be involved in the regulation of neuron guidance, which is important for the development and maintenance of the nervous system. Additionally, PDZD4 has been shown to be involved in the regulation of synaptic plasticity, which is important for the development and maintenance of the nervous system.

PDZD4 has also been shown to play a role in the regulation of hormone signaling, which is important for the regulation of various physiological processes in the endocrine system. For example, studies have shown that PDZD4 can be involved in the regulation of insulin signaling, which is important for the regulation of blood sugar levels. Additionally, PDZD4 has been shown to play a role in the regulation of thyroid hormone signaling, which is important for the regulation of metabolism.

In conclusion, PDZD4 is a protein that is expressed in various tissues of the body and is involved in a

Protein Name: PDZ Domain Containing 4

The "PDZD4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PDZD4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets